Aldeyra Therapeutics Reports Third-Quarter 2019 Financial Results and Provides Updates on Anticipated Clinical Milestones
Go back to Aldeyra Therapeutics Reports Third-Quarter 2019 Financial Results and Provides Updates on Anticipated Clinical Milestones| ALDEYRA THERAPEUT (NASDAQ: ALDX) | Delayed: 2.06 +0.10 (5.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.96 | 52 Week High | $8.19 | |||
| Open | $1.95 | 52 Week Low | $3.39 | |||
| Day High | $2.15 | P/E | N/A | |||
| Day Low | $1.95 | EPS | $0.00 | |||
| Volume | 1,143,785 | |||||
